Fig. 2From: Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case seriesKaplan–Meier survival curves for overall survival (OS) and recurrence-free survival (RFS) in patients with HCC treated with neoadjuvant SBRT and LT. The median OS and RFS were 37.8 and 18.3 months, respectivelyBack to article page